P119 Recurrence Score® result by the 21-gene assay before and after systemic neoadjuvant chemotherapy in patients with HR+ HER2-breast cancer.

N. Ciriaco, B. Vieites, M. Bellet, C. Castilla,P. Gómez Pardo, A. Pérez-Luque,M.Á. López,F.J. Salvador Bofill, L. Alfaro,J.M. Pérez García, M. Espinosa-Bravo, C. Flannery, C. Hagen, V. Peg

The Breast(2023)

引用 0|浏览1
暂无评分
关键词
neoadjuvant chemotherapy,systemic neoadjuvant chemotherapy,cancer
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要